| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 3044.19 | 99 |
| GSM780708 | Untreated after 4 days (C2_1) | 2355.13 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2024.13 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 3081.75 | 99 |
| GSM780720 | Untreated after 4 days (C2_2) | 2572.58 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 2139.94 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2180.74 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 2954.67 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2522 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2017.96 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3188.96 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 2602.65 | 98 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 3412.73 | 99 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2624.14 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2888.43 | 99 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 3319.53 | 99 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2725.25 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2954.67 | 99 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2758.9 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 2937.81 | 99 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 2562.37 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 2624.14 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 2773.32 | 98 |